Join us on the latest episode! Our Guest: Nolan Townsend, CEO of LEXEO Therapeutics

What you'll get out of this episode:

• Can you tell us about your background and what led you to LEXEO?
• What product candidates are development at LEXEO?
• How is what LEXEO is developing different than the current treatments in the neurological and cardiac spaces?
• At BIO you spoke to the topic of accelerated approval, can you provide some perspective on the pathways needed for accelerated approval in gene therapy?
• How does gene therapy address patient needs across disease areas?
• What's next?

Full Video and more info click here: Slice Of Healthcare Website

Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/
FlipMD by GoodRX https://www.goodrx.com/
Quantum Health https://quantum-health.com/

To learn more about LEXEO Therapeutics please use the links below:
- LEXEO TX LinkedIN - LEXEO TX Website -